Skip to main content
. Author manuscript; available in PMC: 2019 Apr 9.
Published in final edited form as: Biomacromolecules. 2018 Mar 19;19(4):1285–1293. doi: 10.1021/acs.biomac.8b00107

Figure 5.

Figure 5.

Dose dependent inhibition of rhEGF-mediated A549 cell proliferation. Cell proliferation was quantified by determining cell numbers 72 h following rhEGF treatment with and without TIMP-2 pretreatment and normalized to basal cell numbers using a MTT assay (as described). Absorbance values were converted to % max EGF proliferation (mean ± SEM, n = 3). Statistical analysis (t test; comparison of 0 nM vs 100 nM for all conditions; n = 3; p ≤ 0.05) was performed using Prism software (v 7.0).